Titan Pharmaceuticals Inc (TTNP) — Capital Reinvestment Ratio
Titan Pharmaceuticals Inc (TTNP) has a Capital Reinvestment Ratio of 0.00x as of June 2016, meaning it reinvests 0% of its operating cash flow ($13.51 Million) in capital expenditures ($9.00K). Check TTNP tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Titan Pharmaceuticals Inc Capital Reinvestment Ratio (1997–2016)
This chart tracks Titan Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Titan Pharmaceuticals Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year Capital Reinvestment Ratio for Titan Pharmaceuticals Inc from 1997 to 2016. See free cash flow generation of Titan Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.03x | $6.29 Million | $171.00K | ▼ -95.7% |
| 2012 | 0.63x | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $7.10 Million | $100.00K | — |